Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate kinase M2 (PKM2) is an isoform of pyruvate kinase that catalyzes the final step of glycolysis, converting phosphoenolpyruvate to pyruvate and generating ATP. It plays critical roles in cellular energy production, anabolic metabolism, and gene expression regulation, particularly in proliferating cells and cancer cells. Its dysregulation is implicated in cancer development, inflammation, and other metabolic diseases, making it a potential therapeutic target.
Inhibition of enzymatic activity; modulation of tetramer-dimer equilibrium; interference with nuclear translocation or protein interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate Kinase M2 Isoform (PKM2).